NeuroPathways Intervention for Brain Tumor Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.
Eligibility criteria
Qualifiers
Age ≥18
Massachusetts General Hospital Cancer Center patient
Within 6 weeks of diagnosis with a primary malignant brain tumor
Able to speak and read in English
Disqualifiers
Inability to provide informed consent as assessed by the study team (e.g., due to neurological impairment such as severe cognitive impairment/dementia or moderate-to-severe receptive aphasia)
Deemed inappropriate to approach by patient's oncologist or study PI
Trial design
Treatments tested in this trial
- Information and Support Intervention
- Usual supportive care
Treatment groups
50 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov